NEW YORK (GenomeWeb) – Taiwanese genomic informatics startup Atgenomix is combining its high-speed data analytics platform with hereditary and cancer mutation analysis workflows from Yourgene Bioscience Taiwan, the companies announced last week.
Through this collaboration, Atgenomix and Yourgene look to offer a unified system for advanced whole-genome sequencing and whole-exome sequencing variant analysis.
Specifically, they will build on the open-source Apache Spark analytics framework to link Yourgene's bioinformatics applications with Atgenomix's computing technology to create a "comprehensive clinical-grade WGS/WES analysis pipeline," the companies said.
"Integrating our solutions will give customers the full spectrum of accelerated whole-genome and exome sequencing analysis with unrivaled bioinformatics expertise, advancing precision medicine from scientific research to clinical use," Atgenomix CEO Allen Chang said in a statement. "Yourgene's global presence also creates an opportunity for Atgenomix to move to the next level of product adoption worldwide."
Atgenomix claims to accelerate workflows 10-fold compared to traditional genomic analysis processes by making even standard desktop computers more efficient in processing genome data.
Yourgene Bioscience Taiwan is a unit of Manchester, UK-based molecular diagnostic company Yourgene Health, formerly known as Premaitha Health. Thermo Fisher Scientific purchased a 9 percent stake in Yourgene Health last month.